Improved dual specificity polypeptide molecule

JP2024023385A5Pending Publication Date: 2026-04-20IMMATICS BIOTECHNOLOGIES GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
IMMATICS BIOTECHNOLOGIES GMBH
Filing Date
2023-11-24
Publication Date
2026-04-20

Smart Images

  • Figure 00000035_0000
    Figure 00000035_0000
  • Figure 00000035_0001
    Figure 00000035_0001
  • Figure 00000035_0002
    Figure 00000035_0002
Patent Text Reader

Abstract

To provide improved bispecific molecules capable of targeting peptide-MHC-complexes, that can be easily produced, display high stability and also provide high potency when binding to the respective antigen epitopes.SOLUTION: The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding region derived from a T cell receptor (TCR) being specific for a major histocompatibility complex (MHC)-associated peptide epitope, and a binding region derived from an antibody capable of recruiting human immune effector cells that specifically bind to a surface antigen of the cells, as well as methods of making the bispecific polypeptide molecule, and uses thereof.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art